Infected alveolar epithelial cells are the main source of IL-33 in the lungs, and activated SARS-CoV-2-derived papain-like protease can efficiently promote these cells to secrete IL-33, particularly in patients with severe COVID-19 [13]. This evidence concerns the gene IL33 and COVID-19.